Pluripotent stem cells pluripotent stemcells concise review: Patient-specific stem cells to interrogate inherited eye disease

Stem Cells Translational Medicine

Volumn 5, Issue 2, 2016, Pages 132-140

  Giacalone, Joseph C ^a   Wiley, Luke A ^a   Burnight, Erin R ^a   Songstad, Allison E ^a   Mullins, Robert F ^a   Stone, Edwin M ^a,b   Tucker, Budd A ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Eye diseases; Eye pathology; Hereditary; Humans; Induced pluripotent stem cells; Retinal degeneration genetics

Indexed keywords

MYOCILIN; OPTINEURIN; TRANSCRIPTION FACTOR OTX2; TRANSCRIPTION FACTOR PAX6; TRANSCRIPTION FACTOR SOX2;

AGE RELATED MACULAR DEGENERATION; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CORNEA DISEASE; EYE DISEASE; GENETIC VARIABILITY; GLAUCOMA; HUMAN; LENS DISEASE; LENS PROGENITOR CELL; NONHUMAN; PATIENT CARE; PHOTORECEPTOR CELL; PIGMENT EPITHELIUM; PLURIPOTENT STEM CELL; RETINA DISEASE; RETINITIS PIGMENTOSA; TRABECULAR MESHWORK; UPREGULATION; ANIMAL; AUTOTRANSPLANTATION; BLINDNESS; CYTOLOGY; DISEASE MODEL; INDUCED PLURIPOTENT STEM CELL; LEBER CONGENITAL AMAUROSIS; MACULAR DEGENERATION; METABOLISM; PATHOLOGY; PERSONALIZED MEDICINE; PHYSIOLOGY; RETINA; STEM CELL TRANSPLANTATION; TRANSPLANTATION;

ANIMALS; BLINDNESS; CELL DIFFERENTIATION; DISEASE MODELS, ANIMAL; GLAUCOMA; HUMANS; INDUCED PLURIPOTENT STEM CELLS; LEBER CONGENITAL AMAUROSIS; MACULAR DEGENERATION; PRECISION MEDICINE; RETINA; RETINITIS PIGMENTOSA; STEM CELL TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS;

EID: 84969441460     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2015-0206     Document Type: Article

References (100)

1. Stone EM, Fingert JH, Alward WL et al. Identification of a gene that causes primary open angle glaucoma. Science 1997;275:668-670.
2. Cavenee WK, Hansen MF, Nordenskjold M et al. Genetic origin of mutations predisposing to retinoblastoma. Science 1985;228:501-503.
3. Roepman R, van Duijnhoven G, Rosenberg T et al. Positional cloning of the gene for X-linked retinitis pigmentosa 3: Homology with the guanine-nucleotide-exchange factor RCC1. Hum Mol Genet 1996;5:1035-1041.
4. Meindl A, Dry K, Herrmann K et al. A gene (RPGR) with homology to the RCC1 guanine nucleotide exchange factor is mutated in X-linked retinitis pigmentosa (RP3). Nat Genet 1996;13: 35-42.
5. Stone EM, Lotery AJ, Munier FL et al. A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy. Nat Genet 1999;22:199-202.
6. Huopaniemi L, Rantala A, Tahvanainen E et al. Linkage disequilibrium and physical mapping of X-linked juvenile retinoschisis. Am J Hum Genet 1997;60:1139-1149.
7. Sahly I, Dufour E, Schietroma C et al. Localization of Usher 1 proteins to the photoreceptor calyceal processes, which are absent from mice. J Cell Biol 2012;199:381-399.
8. Takahashi K, Tanabe K, Ohnuki M et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131:861-872.
9. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-676.
10. Wiley LA, Burnight ER, Songstad AE et al. Patient-specific induced pluripotent stem cells (iPSCs) for the study and treatment of retinal degenerative diseases. Prog Retin Eye Res 2015;44:15-35.
11. Wiley LA, Burnight ER, Mullins RF et al. Stem cells as tools for studying the genetics of inherited retinal degenerations. Cold Spring Harb Perspect Med 2015;5:a017160.
12. Burnight ER, Wiley LA, Mullins RF et al. Gene therapy using stem cells. Cold Spring Harb Perspect Med 2015;5:a017434.
13. Zhong X, Gutierrez C, Xue T et al. Generation of three-dimensional retinal tissue with functional photoreceptors from human iPSCs. Nat Commun 2014;5:4047.
14. Soldner F, Jaenisch R. Medicine: iPSC disease modeling. Science 2012;338:1155-1156.
15. DelMonte DW, Kim T. Anatomy and physiology of the cornea. J Cataract Refract Surg 2011;37:588-598.
16. Pellegrini G, Golisano O, Paterna P et al. Location and clonal analysis of stem cells and their differentiated progeny in the human ocular surface. J Cell Biol 1999;145:769-782.
17. Shortt AJ, Secker GA, Munro PM et al. Characterization of the limbal epithelial stem cell niche: Novel imaging techniques permit in vivo observation and targeted biopsy of limbal epithelial stem cells. STEM CELLS 2007;25:1402-1409.
18. Sareen D, Saghizadeh M, Ornelas L et al. Differentiation of human limbal-derived induced pluripotent stem cells into limbal-like epithelium. STEM CELLS TRANSLATIONAL MEDICINE 2014;3:1002-1012. www.StemCellsTM.com
19. Hayashi R, Ishikawa Y, Ito M et al. Generation of corneal epithelial cells from induced pluripotent stem cells derived from human dermal fibroblast and corneal limbal epithelium. PLoS One 2012;7:e45435.
20. Chen P, Chen J-Z, Shao C-Y et al. Treatment with retinoic acid and lens epithelial cell-conditioned medium in vitro directed the differentiation of pluripotent stem cells towards corneal endothelial cell-like cells. Exp Ther Med 2015;9:351-360.
21. Shi Y, De Maria A, Lubura S et al. The penny pusher: A cellular model of lens growth. Invest Ophthalmol Vis Sci 2015;56:799-809.
22. Wiley LA, Shui Y-B, Beebe DC. Visualizing lens epithelial cell proliferation in whole lenses. Mol Vis 2010;16:1253-1259.
23. Wiley LA, Rajagopal R, Dattilo LK et al. The tumor suppressor gene Trp53 protects the mouse lens against posterior subcapsular cataracts and the BMP receptor Acvr1 acts as a tumor suppressor in the lens. Dis Model Mech 2011;4:484-495.
24. Lovicu FJ, McAvoy JW, de Iongh RU. Understanding the role of growth factors in embryonic development: Insights from the lens. Philos Trans R Soc Lond B Biol Sci 2011;366: 1204-1218.
25. Qiu X, Yang J, Liu T et al. Efficient generation of lens progenitor cells from cataract patient-specific induced pluripotent stem cells. PLoS One 2012;7:e32612.
26. Tucker BA, Scheetz TE, Mullins RF et al. Exome sequencing and analysis of induced pluripotent stem cells identify the cilia-related gene male germ cell-associated kinase (MAK) as a cause of retinitis pigmentosa. Proc Natl Acad Sci USA 2011;108:E569-E576.
27. Tucker BA, Mullins RF, Streb LM et al. Patient-specific iPSC-derived photoreceptor precursor cells as a means to investigate retinitis pigmentosa. eLife 2013;2:e00824.
28. Tucker BA, Anfinson KR, Mullins RF et al. Use of a synthetic xeno-free culture substrate for induced pluripotent stem cell induction and retinal differentiation. STEM CELLS TRANSLA-TIONAL MEDICINE 2013;2:16-24.
29. Congdon N, Vingerling JR, Klein BEK et al. Prevalence of cataract and pseudophakia/aphakia among adults in the United States. Arch Ophthalmol 2004;122:487-494.
30. Gohdes DM, Balamurugan A, Larsen BA et al. Age-related eye diseases: An emerging challenge for public health professionals. Prev Chronic Dis 2005;2:A17.
31. Goel M, Picciani RG, Lee RK et al. Aqueous humor dynamics: A review. Open Ophthalmol J 2010;4:52-59.
32. Du Y, Roh DS, Mann MM et al. Multipotent stem cells from trabecular meshwork become phagocytic TM cells. Invest Ophthalmol Vis Sci 2012;53:1566-1575.
33. Fingert JH, Robin AL, Stone JL et al. Copy number variations on chromosome 12q14 in patients with normal tension glaucoma. Hum Mol Genet 2011;20:2482-2494.
34. Libby RT, Gould DB, Anderson MG et al. Complex genetics of glaucoma susceptibility. Annu Rev Genomics Hum Genet 2005;6:15-44.
35. Rezaie T, Child A, Hitchings R et al. Adultonset primary open-angle glaucoma caused by mutations in optineurin. Science 2002;295: 1077-1079.
36. Moses RA. The effect of intraocular pressure on resistance to outflow. Surv Ophthalmol 1977;22:88-100.
37. Tamm ER, Fuchshofer R. What increases outflow resistance in primary open-angle glaucoma? Surv Ophthalmol 2007;52(suppl 2): S101-S104.
38. Ding QJ, Zhu W, Cook AC et al. Induction of trabecular meshwork cells from induced pluripotent stem cells. Invest Ophthalmol Vis Sci 2014;55:7065-7072.
39. Purves D, Augustine GJ, Fitzpatrick D et al., eds. Neuroscience. The Retina. 2nd ed. Sunderland, MA: Sinauer Associates, 2001.
40. Wright AF, Chakarova CF, Abd El-Aziz MM et al. Photoreceptor degeneration: Genetic and mechanistic dissection of a complex trait. Nat Rev Genet 2010;11:273-284.
41. Masland RH. The fundamental plan of the retina. Nat Neurosci 2001;4:877-886.
42. Purves D, Augustine GJ, Fitzpatrick D et al., eds. Neuroscience. Chapter 12: Central Visual Pathways. 2nd edition. Sunderland, MA: Sinauer Associates; 2001.
43. Baker SA, Kerov V. Photoreceptor inner and outer segments. Curr Top Membr 2013; 72:231-265.
44. Fu Y. Phototransduction in rods and cones. In: Kolb H, Fernandez E, Nelson R, eds. Webvision: The Organization of the Retina and Visual System. University of Utah Health Sciences Center. Available at http://webvision.med.utah.edu/book/part-v-phototransduction-in-rods-and-cones/phototransduction-in-rods-and-cones/.Accessed September 21, 2015.
45. Strauss O. The retinal pigment epithelium in visual function. Physiol Rev 2005;85:845-881.
46. Baehr W, Wu SM, Bird AC et al. The retinoid cycle and retina disease. Vision Res 2003;43:2957-2958.
47. Nickla DL, Wallman J. The multifunctional choroid. Prog Retin Eye Res 2010;29:144-168.
48. Tucker BA, Park I-H, Qi SD et al. Transplantation of adult mouse iPS cell-derived photoreceptor precursors restores retinal structure and function in degenerative mice. PLoS One 2011;6:e18992.
49. Lamba DA, McUsic A, Hirata RK et al. Generation, purification and transplantation of photoreceptors derived from human induced pluripotent stem cells. PLoS One 2010;5:e8763.
50. Lamba DA, Karl MO, Ware CB. Efficient generation of retinal progenitor cells from human embryonic stem cells. Proc Natl Acad Sci USA 2006;103:12769-12774.
51. Jin Z-B, Okamoto S, Xiang P et al. Integration-free induced pluripotent stem cells derived from retinitis pigmentosa patient for disease modeling. STEM CELLS TRANSLATIONAL MEDICINE 2012;1:503-509.
52. Osakada F, Jin Z-B, Hirami Y et al. In vitro differentiation of retinal cells from human pluripotent stem cells by small-molecule induction. J Cell Sci 2009;122:3169-3179.
53. Buchholz DE, Pennington BO, Croze RH et al. Rapid and efficient directed differentiation of human pluripotent stem cells into retinal pigmented epithelium. STEM CELLS TRANSLA-TIONAL MEDICINE 2013;2:384-393.
54. Buchholz DE, Hikita ST, Rowland TJ et al. Derivation of functional retinal pigmented epithelium from induced pluripotent stem cells. STEM CELLS 2009;27:2427-2434.
55. Meyer JS, Shearer RL, Capowski EE et al. Modeling early retinal development with human embryonic and induced pluripotent stem cells. Proc Natl Acad Sci USA 2009;106: 16698-16703.
56. Phillips MJ, Wallace KA, Dickerson SJ et al. Blood-derived human iPS cells generate optic vesicle-like structures with the capacity to form retinal laminae and develop synapses. Invest Ophthalmol Vis Sci 2012;53:2007-2019.
57. Nakano T, Ando S, Takata N et al. Self-formation of optic cups and storable stratified neural retina from human ESCs. Cell Stem Cell 2012;10:771-785.
58. Eiraku M, Takata N, Ishibashi H et al. Self-organizing optic-cup morphogenesis in three-dimensional culture. Nature 2011;472:51-56.
59. Eiraku M, Sasai Y. Mouse embryonic stem cell culture for generation of three-dimensional retinal and cortical tissues. Nat Protoc 2012;7: 69-79.
60. Jager RD, Mieler WF, Miller JW. Agerelated macular degeneration. N Engl J Med 2008;358:2606-2617.
61. Sheffield VC, Stone EM. Genomics and the eye. N Engl J Med 2011;364:1932-1942.
62. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006;90:262-267.
63. Ferrari S, Di Iorio E, Barbaro V et al. Retinitis pigmentosa: Genes and disease mechanisms. Curr Genomics 2011;12:238-249.
64. Perrault I, Rozet JM, Gerber S et al. Leber congenital amaurosis. Mol Genet Metab 1999; 68:200-208.
65. Veleri S, Lazar CH, Chang B et al. Biology and therapy of inherited retinal degenerative disease: Insights from mouse models. Dis Model Mech 2015;8:109-129.
66. Singh R, Shen W, Kuai D et al. iPS cell modeling of Best disease: Insights into the pathophysiology of an inherited macular degeneration. Hum Mol Genet 2013;22:593-607.
67. Klassen HJ, Ng TF, Kurimoto Y et al. Multipotent retinal progenitors express developmental markers, differentiate into retinal neurons, and preserve light-mediated behavior. Invest Ophthalmol Vis Sci 2004;45:4167-4173.
68. MacLaren RE, Pearson RA, MacNeil A et al. Retinal repair by transplantation of photo receptor precursors. Nature 2006;444: 203-207.
69. Carr A-J, Vugler AA, Hikita ST et al. Protective effects of human iPS-derived retinal pigment epithelium cell transplantation in the retinal dystrophic rat. PLoS One 2009;4:e8152.
70. Phillips MJ, Perez ET, Martin JM et al. Modeling human retinal development with patient-specific induced pluripotent stem cells reveals multiple roles for visual system homeo-box 2. STEM CELLS 2014;32:1480-1492.
71. Ran X, Cai W-J, Huang X-F et al. “Retino-Genetics”: A comprehensive mutation database for genes related to inherited retinal degeneration. Database (Oxford) 2014;2014:bau047.
72. Tucker BA, Solivan-Timpe F, Roos BR et al. Duplication of TBK1 stimulates autophagy in iPSC-derived retinal cells from a patient with normal tension glaucoma. J Stem Cell Res Ther 2014;3:161.
73. Liu Y, Levine B. Autosis and autophagic cell death: The dark side of autophagy. Cell Death Differ 2015;22:367-376.
74. Pascolini D, Mariotti SP, Pokharel GP et al. 2002 Global update of available data on visual impairment: A compilation of population-based prevalence studies. Ophthalmic Epidemiol 2004;11:67-115.
75. Seddon JM, Cote J, Page WF et al. The US twin study of age-related macular degeneration: Relative roles of genetic and environmental influences. Arch Ophthalmol 2005;123: 321-327.
76. Fritsche LG, Chen W, Schu M et al. Seven new loci associated with age-related macular degeneration. Nat Genet 2013;45:433-439.
77. Campa C, Harding SP. Anti-VEGF compounds in the treatment of neovascular age related macular degeneration. Curr Drug Targets 2011;12:173-181.
78. Stone EM. A very effective treatment for neovascular macular degeneration. N Engl J Med 2006;355:1493-1495.
79. Scott AW, Bressler SB. Long-term follow- up of vascular endothelial growth factor inhibitor therapy for neovascular age-related macular degeneration. Curr Opin Ophthalmol 2013;24: 190-196.
80. Schwartz SD, Hubschman J-P, Heilwell G et al. Embryonic stem cell trials for macular degeneration: A preliminary report. Lancet 2012; 379:713-720.
81. Schwartz SD, Regillo CD, Lam BL et al. Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt’s macular dystrophy: Follow-up of two open-label phase 1/2 studies. Lancet 2015;385:509-516.
82. Croze RH, Buchholz DE, Radeke MJ et al. ROCK inhibition extends passage of pluripotent stem cell-derived retinal pigmented epithelium. STEM CELLS TRANSLATIONAL MEDICINE 2014; 3:1066-1078.
83. Croze RH, Clegg DO. Differentiation of pluripotent stem cells into retinal pigmented epithelium. Dev Ophthalmol 2014;53:81-96.
84. Kamao H, Mandai M, Okamoto S et al. Characterization of human induced pluripotent stem cell-derived retinal pigment epithelium cell sheets aiming for clinical application. Stem Cell Rep 2014;2:205-218.
85. Yang J, Li Y, Chan L et al. Validation of genome-wide association study (GWAS)-identified disease risk alleles with patient- specific stem cell lines. Hum Mol Genet 2014; 23:3445-3455.
86. Jin ZB, Okamoto S, Osakada F et al. Modeling retinal degeneration using patient-specific induced pluripotent stem cells. PLoS One 2011; 6:e17084.
87. Burnight ER, Wiley LA, Drack AV et al. CEP290 gene transfer rescues Leber congenital amaurosis cellular phenotype. Gene Ther 2014; 21:662-672.
88. Drivas TG, Holzbaur ELF, Bennett J. Disruption of CEP290 microtubule/membrane-binding domains causes retinal degeneration. J Clin Invest 2013;123:4525-4539.
89. Lustremant C, Habeler W, Plancheron A et al. Human induced pluripotent stem cells as a tool to model a form of Leber congenital amaurosis. Cell Reprogram 2013;15:233-246.
90. Yoshida T, Ozawa Y, Suzuki K et al. The use of induced pluripotent stem cells to reveal pathogenic gene mutations and explore treatments for retinitis pigmentosa. Mol Brain 2014;7:45.
91. Burns ME, Baylor DA. Activation, deactivation, and adaptation in vertebrate photoreceptor cells. Annu Rev Neurosci 2001;24: 779-805.
92. Bainbridge JWB, Smith AJ, Barker SS et al. Effect of gene therapy on visual function in Leber’s congenital amaurosis. N Engl J Med 2008; 358:2231-2239.
93. Hauswirth WW, Aleman TS, Kaushal S et al. Treatment of Leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: Short-term results of a phase I trial. Hum Gene Ther 2008;19:979-990.
94. Jacobson SG, Cideciyan AV, Ratnakaram R et al. Gene therapy for Leber congenital amaurosis caused by RPE65 mutations: Safety and efficacy in 15 children and adults followed up to 3 years. Arch Ophthalmol 2012;130:9-24.
95. Maguire AM, High KA, Auricchio A et al. Age-dependent effects of RPE65 gene therapy for Leber’s congenital amaurosis: A phase 1 dose-escalation trial. Lancet 2009; 374:1597-1605.
96. Tucker BA, Cranston C, Anfinson KR et al. Using patient specific iPSCs to interrogate the pathogenicity of a novel RPE65 cryptic splice site mutation and confirm eligibility for enrollment into a clinical gene augmentation trial. Transl Res 2015 [Epub ahead of print].
97. Meyer JS, Howden SE, Wallace KA et al. Optic vesicle-like structures derived from human pluripotent stem cells facilitate a customized approach to retinal disease treatment. STEM CELLS 2011;29:1206-1218.
98. Howden SE, Gore A, Li Z et al. Genetic correction and analysis of induced pluripotent stem cells from a patient with gyrate atrophy. Proc Natl Acad Sci USA 2011;108:6537-6542.
99. Li Y, Wu W-H, Hsu C-W et al. Gene therapy in patient-specific stem cell lines and a preclinical model of retinitis pigmentosa with membrane frizzled-related protein defects. Mol Ther 2014;22:1688-1697.
100. Schwarz N, Carr A-J, Lane A et al. Translational read-through of the RP2 Arg120stop mutation in patient iPSC-derived retinal pigment epithelium cells. Hum Mol Genet 2015; 24:972-986.